Enhancement of ampicillin efficacy by peroral levodopa in rat pyelonephritis.
D000284:Administration, Oral; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D002396:Catechols / Q000008:administration & dosage / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004357:Drug Synergism; D004492:Edetic Acid / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy*; D009582:Nitrofurantoin / Q000627:therapeutic use; D010648:Phenylacetates / Q000008:administration & dosage / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy*; D051381:Rats; D013997:Time Factors
D002396:Catechols; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D000667:Ampicillin; D009582:Nitrofurantoin; D004492:Edetic Acid; D002512:Cephalothin